Beginning April 1, 2026, we’ll require prior authorization for some new procedure codes that the American Medical Association has created for genetic and molecular testing. These codes are consistent with genetic and molecular tests that currently require prior authorization.
This affects the following participating UnitedHealthcare commercial plans and UnitedHealthcare Individual Exchange plans in all states:
In addition to the current in-scope procedure codes, we’ll add the following code to the existing prior authorization/advance notification requirements:
If we don’t receive a prior authorization request before the date of service, we’ll deny the claim and you won’t be able to balance bill members.
If you have questions, please visit our Prior Authorization and Notification resource.
PCA-1-25-02490-Clinical-NN_12012025